Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MERCURY NZ LIMITED Director's Dealing 2021

Oct 8, 2021

65306_rns_2021-10-08_16773e1b-f654-4842-9f01-9dcf1e09c3d9.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [62 x 19] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

ToNZX Limited; and
Name of listed issuer: MercuryNZ Limited
Date this disclosure made: 8 October 2021
Date of last disclosure: 30 July2021
Director or senior managergiving disclosure
Full name(s): StewartAllan Hamilton
Name of listed issuer: MercuryNZ Limited
Name of related body corporate (if applicable): N/A
Position held in listed issuer: GMGeneration

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products: Ordinary shares (NZX: MCY)
Nature of the affected relevant interest(s): Registered holder and beneficialowner Power to acquire ordispose of, or to controlthe acquisition ordisposition of, or power toexercise, or to control theexercise of, a right to voteattached to ordinaryshares Power to acquire or disposeof, or to control theacquisition or disposition of,or power to exercise, or tocontrol the exercise of, a rightto vote attached to ordinaryshares
For that relevant interest-
Number held in class before acquisition or disposal: 1,040* 1,040* 1,040*
Number held in class after acquisition or disposal: 00 0
Current registered holder(s): Stewart Allan Hamilton Lara Nicole Hamilton Aimee Elizabeth Hamilton
Registered holder(s)once transfers are registered: Unknown Unknown Unknown
* Initial disclosure made on 30 July 2021 incorrectly stated that 1,500 shares were held in
Note: respect of each of the relevant interests above. The number held in class before the disposalstated above of 1,040 shares for each relevant interest was the correct number at the time of
the initial disclosure and did not change prior to the disposal giving rise to this notice.
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: Not applicable
Class of underlyingfinancialproducts: Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financialproducts(if any): Not applicable
A statement as to whether the derivative is cash settled orphysicallysettled: Not applicable
Maturitydate of the derivative(if any): Not applicable
Expirydate of the derivative(if any): Not applicable
Theprice specified in the terms of the derivative(if any): Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products: Not applicable
_For that derivative,- _ Not applicable
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative: Not applicable
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates: 3

Details of transactions requiring disclosure-

Details of transactions requiring disclosure-
Date oftransaction: 1October 2021
On market disposal of ordinary
Nature of transaction: shares
Name ofany otherparty orparties to the transaction(if known): Unknown
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value,describe the consideration: $20,163
Numberof financialproducts towhichthe transaction related: 3,120 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period: No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod: Not applicable
Date of theprior written clearance(if any): Not applicable
Summary of other relevant interests after acquisition or disposal:
Class ofquotedfinancialproducts: Not applicable
Nature of relevantinterest: Not applicable
_For that relevant interest,- _
Number heldinclass: Not applicable
Currentregisteredholder(s): Not applicable
For a derivative relevant interest,-
Type ofderivative: Not applicable

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

==> picture [132 x 106] intentionally omitted <==

Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable

Certification

I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

8 October 2021 Kendal Luskie, Legal Counsel